VRPX
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
VRPX
Delisted
VRPX was delisted on the 3rd of April, 2025.
16 hedge funds and large institutions have $3.13M invested in Virpax Pharmaceuticals, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 3 closing their positions.
Holders
16
Holders Change
–
Holders Change %
0%
% of All Funds
0.27%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
6
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
KC
1
Kepos Capital
New York
|
$0 |
| 2 |
2
Morgan Stanley
New York
|
$30K |
| 3 |
3
Citigroup
New York
|
$0 |
| 4 |
4
JPMorgan Chase & Co
New York
|
$0 |
| 5 |
5
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
$28K |
